TNFRSF11B gene variants and bone mineral density in postmenopausal women in Malta.
A number of polymorphisms in various genes have been identified and associated with bone mineral density (BMD) and with an increased risk of osteoporosis.


OBJECTIVE
In this study, three single nucleotide polymorphisms (SNPs) within the TNFRSF11B gene were studied for association with an increased risk of osteoporosis in postmenopausal Maltese women (n=126).


METHODS
Analysis was performed by PCR restriction fragment length polymorphism (RFLP) while BMD at the lumbar spine, femoral neck, Ward's triangle and trochanter was measured by DEXA.


RESULTS
No significant association was observed between genotypes and BMD for all polymorphisms studied within this gene. Homozygotes CC (T(950)-C) were observed to have the highest BMD at all anatomical sites although statistical significance was not reached when comparing the three genotypes. A statistical significant difference was observed in the distribution of genotype frequencies for this polymorphism between normal individuals and those that were either osteopenic or osteoporotic at one or both anatomical sites, with the TT genotype associated more frequently with low BMD. The T(950)-C and G(1181)-C polymorphisms were in strong linkage disequilibrium with each other but not with the A(163)-G polymorphism further upstream in the OPG promoter. Statistical significance was reached when constructing haplotypes, where the A-T-G haplotype was found to be more frequent in individuals with low BMD.


CONCLUSIONS
These results indicate the possible role of TNFRSF11B gene variants in postmenopausal bone loss in women in Malta.
Vidal
C
C
Department of Pathology, University of Malta Medical School, Malta.
Brincat
M
M
Xuereb Anastasi
A
A
D015502:Absorptiometry, Photon; D000368:Aged; D000704:Analysis of Variance; D015415:Biomarkers / Q000097:blood / Q000652:urine; D016723:Bone Remodeling / Q000235:genetics*; D005260:Female; D006023:Glycoproteins / Q000235:genetics*; D006239:Haplotypes / Q000235:genetics; D006801:Humans; D008319:Malta / Q000208:ethnology; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000235:genetics*; D053244:Osteoprotegerin; D020641:Polymorphism, Single Nucleotide / Q000235:genetics* / Q000502:physiology; D018160:Receptors, Cytoplasmic and Nuclear / Q000235:genetics*; D018124:Receptors, Tumor Necrosis Factor / Q000235:genetics*; D012307:Risk Factors; D018709:Statistics, Nonparametric
D015415:Biomarkers; D006023:Glycoproteins; D053244:Osteoprotegerin; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor; C506030:TNFRSF11B protein, human